VCEL FY 2021 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$156M+25.8% YoY

Gross Profit

$106M67.9% margin

Operating Income

-$8M-5.0% margin

Net Income

-$7M-4.8% margin

EPS (Diluted)

$-0.16

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$21M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$244M

Total Liabilities

$73M

Stockholders' Equity

$170M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$156M	$124M	+25.8%
Gross Profit	$106M	$84M	+25.9%
Operating Income	-$8M	$2M	-431.1%
Net Income	-$7M	$3M	-360.9%